Contineum Therapeutics, Inc. Class A Common Stock (CTNM)
Company Profile
| Document And Entity Information | Aug. 13, 2024 |
| Document Information [Line Items] | |
| Entity, Registrant Name | Contineum Therapeutics, Inc. |
| Document, Type | 8-K/A |
| Document, Period End Date | Aug. 13, 2024 |
| Entity, Incorporation, State or Country Code | DE |
| Entity, File Number | 001-42001 |
| Entity, Tax Identification Number | 27-1467257 |
| Entity, Address, Address Line One | 10578 Science Center Drive, Suite 200 |
| Entity, Address, City or Town | San Diego |
| Entity, Address, State or Province | CA |
| Entity, Address, Postal Zip Code | 92121 |
| City Area Code | 858 |
| Local Phone Number | 333-5280 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Class A Common Stock |
| Trading Symbol | CTNM |
| Security Exchange Name | NASDAQ |
| Entity, Emerging Growth Company | true |
| Entity, Ex Transition Period | false |
| Amendment Description | Q2'24 8-K/A |
| Amendment Flag | true |
| Entity, Central Index Key | 0001855175 |